NM_000517.6:c.142G>C

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PP3_ModeratePP5_Very_Strong

The NM_000517.6(HBA2):​c.142G>C​(p.Asp48His) variant causes a missense change. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D48Y) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000040 ( 0 hom., cov: 12)
Exomes 𝑓: 0.000042 ( 0 hom. )

Consequence

HBA2
NM_000517.6 missense

Scores

9
4
3

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:6O:4

Conservation

PhyloP100: 5.34

Publications

2 publications found
Variant links:
Genes affected
HBA2 (HGNC:4824): (hemoglobin subunit alpha 2) The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008]
HBA2 Gene-Disease associations (from GenCC):
  • alpha thalassemia spectrum
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
  • erythrocytosis, familial, 7
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae)
  • hemoglobin M disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hb Bart's hydrops fetalis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hemoglobin H disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Heinz body anemia
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • methemoglobinemia, alpha type
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • unstable hemoglobin disease
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 12 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 4 benign, 11 uncertain in NM_000517.6
PP3
MetaRNN computational evidence supports a deleterious effect, 0.934
PP5
Variant 16-173171-G-C is Pathogenic according to our data. Variant chr16-173171-G-C is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 15636.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000517.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HBA2
NM_000517.6
MANE Select
c.142G>Cp.Asp48His
missense
Exon 2 of 3NP_000508.1D1MGQ2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HBA2
ENST00000251595.11
TSL:1 MANE Select
c.142G>Cp.Asp48His
missense
Exon 2 of 3ENSP00000251595.6P69905
HBA2
ENST00000484216.1
TSL:1
c.109G>Cp.Asp37His
missense
Exon 2 of 2ENSP00000495899.1A0A2R8Y7C0
HBA2
ENST00000482565.1
TSL:1
n.278G>C
non_coding_transcript_exon
Exon 1 of 2

Frequencies

GnomAD3 genomes
AF:
0.0000401
AC:
4
AN:
99842
Hom.:
0
Cov.:
12
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00143
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000945
AC:
12
AN:
126964
AF XY:
0.0000438
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00161
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000254
GnomAD4 exome
AF:
0.0000416
AC:
33
AN:
793608
Hom.:
0
Cov.:
11
AF XY:
0.0000243
AC XY:
10
AN XY:
411868
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
17340
American (AMR)
AF:
0.00
AC:
0
AN:
36092
Ashkenazi Jewish (ASJ)
AF:
0.00114
AC:
24
AN:
21082
East Asian (EAS)
AF:
0.00
AC:
0
AN:
33606
South Asian (SAS)
AF:
0.00
AC:
0
AN:
66624
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
34524
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2848
European-Non Finnish (NFE)
AF:
0.00000736
AC:
4
AN:
543748
Other (OTH)
AF:
0.000132
AC:
5
AN:
37744
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000401
AC:
4
AN:
99842
Hom.:
0
Cov.:
12
AF XY:
0.0000426
AC XY:
2
AN XY:
46988
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
17818
American (AMR)
AF:
0.00
AC:
0
AN:
10236
Ashkenazi Jewish (ASJ)
AF:
0.00143
AC:
4
AN:
2792
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3720
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2312
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
7246
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
264
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53556
Other (OTH)
AF:
0.00
AC:
0
AN:
1230
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000240
Hom.:
0
ExAC
AF:
0.0000402
AC:
4

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
3
-
-
not provided (3)
2
-
-
alpha Thalassemia (2)
1
-
-
alpha Thalassemia;C0700299:Heinz body anemia;C3161174:Hemoglobin H disease;C4693823:Erythrocytosis, familial, 7 (1)
-
-
-
HEMOGLOBIN HASHARON (1)
-
-
-
HEMOGLOBIN L (FERRARA) (1)
-
-
-
HEMOGLOBIN SEALY (1)
-
-
-
HEMOGLOBIN SINAI (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.76
BayesDel_addAF
Pathogenic
0.48
D
BayesDel_noAF
Pathogenic
0.45
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.050
T
Eigen
Benign
0.18
Eigen_PC
Benign
0.10
FATHMM_MKL
Pathogenic
0.98
D
M_CAP
Pathogenic
0.68
D
MetaRNN
Pathogenic
0.93
D
MetaSVM
Uncertain
0.59
D
PhyloP100
5.3
PrimateAI
Uncertain
0.73
T
PROVEAN
Pathogenic
-6.6
D
REVEL
Pathogenic
0.79
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.0060
D
Vest4
0.62
MutPred
0.96
Gain of disorder (P = 0.1421)
MVP
1.0
MPC
1.9
ClinPred
0.67
D
GERP RS
3.2
PromoterAI
-0.046
Neutral
gMVP
0.88
Mutation Taster
=8/92
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs281864834; hg19: chr16-223170; API